Overview

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Apatinib dose titration in Advanced or Metastatic Gastric Cancer
Phase:
N/A
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Apatinib